Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

in response to

Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

Toinv

posted on May 30, 2017 12:47PM

Toinv - I believe the IP library of RVX is 2400 compounds with multiple scaffolds and Zenith has 1500 compounds again with multiple scaffolds. Any potential acquisitor has to be looking at not only what "is" right now but what "could be" in the future with the under developed part of the library. I will continue with my thought that whoever ends up buying us will have made the best investment decision in the history of their company.

So much science, so little money...at this point.

DYODD

tada

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply